Understanding genetic testing

Genetic Testing to assess hereditary cancer risk
Good to know about genetic testing

Genetic testing is a powerful tool that analyzes a person's DNA to identify changes or mutations in specific genes, chromosomes, or proteins. These changes can provide valuable information about a person's risk of developing certain genetic disorders, including hereditary cancers.

How genetic testing works:

  1. Sampling: A sample of the person's blood, saliva or tissue is collected. The choice of sample type depends on the specific test to be performed. At Eiira, we collect saliva samples to predict cancer risk.
  2. DNA extraction: The DNA is extracted from the sample and purified for testing.
  3. Analysis: The DNA is analyzed using various techniques, such as sequencing, to identify specific changes or mutations in the genes of interest.
  4. Interpretation: Genetic professionals interpret the results and determine their significance. They evaluate whether the identified changes are linked to an increased risk of developing a particular condition or disease, such as cancer.
  5. Reporting: The results are shared with the individual and/or their healthcare provider, who can then use the information to make informed decisions about prevention, screening, and treatment.

What genetic testing can reveal about a person's cancer risk: Genetic testing can help determine if an individual carries gene mutations associated with an increased risk of certain hereditary cancers. These tests can be particularly useful for people with a strong family history of cancer or those who have specific types of cancer that are more likely to be hereditary.

Some of the most common hereditary cancer syndromes include:

  1. Hereditary Breast and Ovarian Cancer (HBOC) Syndrome: Associated with mutations in the BRCA1 and BRCA2 genes, this syndrome increases the risk of breast, ovarian, and other types of cancer.
  2. Lynch syndrome: Lynch syndrome is caused by mutations in genes such as MLH1, MSH2, MSH6 and PMS2 and increases the risk of colorectal, endometrial and other cancer types.
  3. Familial Adenomatous Polyposis (FAP): Resulting from mutations in the APC gene, FAP significantly increases the risk of colorectal cancer and other malignancies.

It is important to remember that genetic tests can reveal an increased risk of hereditary cancer, but they do not guarantee that a person will develop cancer. The results help individuals and their healthcare providers to make informed decisions about prevention, lifestyle choices and expanded cancer screening to reduce risk and detect cancer early if it develops.

Genetic tests can also have limitations, as they do not always provide clear answers about a person's risk. Some genetic tests may reveal gene variants of uncertain significance, meaning their impact on cancer risk is unclear. Current practice among healthcare providers recommends not communicating such information to the patient until it becomes clear.


  1. National Cancer Institute. (2021). Genetic Testing for Hereditary Cancer Syndromes.
  2. American Cancer Society (2021). Genetic Testing, Screening, and Prevention for People with a Strong Family History of Colorectal Cancer.
  3. Mayo Clinic. (2021). Genetic Testing.

Share on social media

Our products

Eiira Classic Genetic Test Kit for Hereditary Cancer Risk

Eiira Classic

A genetic test for hereditary cancer prevention

  • Simple genetic test done at home
  • Discover hereditary risks for 10 most common cancers
  • Take actions with preventive measures

4990 kr

12 installments for only 460 kr/month (5516 kr total)

Learn more
Eiira Premium Genetic Test Kit for hereditary cancer assessment

Eiira Premium

A genetic test for hereditary cancer prevention

All benefits from Eiira Classic plus:

  • Discovery of rare hereditary cancer risks
  • Information covering 100% of your genome
  • Enjoy lifetime updates of what future science can offer for preventive healthcare

9990 kr

12 installments for only 921 kr/month (11043 kr total)

Learn more

Set-up fee 0 kr, administrative fee 0 kr/month, fixed annual interest 18.9%, effective interest 20.6%. Totals include estimated amount of credit of 526 kr for Eiira Classic and 1053 kr for Eiira Premium. Applies to 12 months of installments with Klarna. Creditor and payee: Klarna Bank AB (publ) Sveavägen 46, 111 34 Stockholm. The amounts shown are an indication. Exact cost varies depending on which day of the month the purchase is made. For complete terms and conditions, read more at klarna.com/se/villkor